Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for PAD-Related Intermittent Claudication
NCT01799057Phase 4Terminated
- Sponsor
- Baker Heart and Diabetes Institute
- Start
- Jul 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liquid metformin (Aspargo Labs) in peripheral artery disease (PAD), intermittent claudication (IC), sponsored by Baker Heart and Diabetes Institute. Started Jul 2013; status: terminated.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
peripheral artery disease (PAD)intermittent claudication (IC)
Beyond the preview
Go deeper on NCT01799057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01799057.